ASEAN: EMERGING HOTSPOT FOR BIG PHARMAS ASEAN is growing, and growing with it is the region’s pharma sector. With growth in developed markets flattening, pharma industry is betting on lucrative ASEAN markets for profits. Think of Asia’s emerging markets and the instant names that appear are India and China. Undoubtedly, these are huge markets for the industry. But apart from these main markets, ASEAN’s emerging markets, with an annual growth rate of 11 per cent and huge untapped potential, provide a massive opportunity for big pharma to expand and grow in this region. 29